Selection of agents modulating gastrointestinal pain
US10656141B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 16, 2018 |
| Grant date | May 19, 2020 |
| Priority date | — |
| Expiry date | May 16, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present embodiments relate to selection of agents effective in reducing or preventing gastrointestinal pain in a subject. Such an agent is selected and identified if it is capable of reducing spontaneous and/or induced transient receptor potential vanilloid 1 (TRPV1) activation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.